Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases
Zaruhi Hovhannisyan, Jacquelyn Treatman, Dan R Littman, Lloyd Mayer, Zaruhi Hovhannisyan, Jacquelyn Treatman, Dan R Littman, Lloyd Mayer
Abstract
Background & aims: Interleukin (IL)-17-producing CD4(+) helper T cells (Th17) mediate mucosal immunity and are involved in the pathogenesis of inflammatory bowel disease (IBD). They are believed to arise from the same precursor population as regulatory T (Treg) cells, but little is known about how these T-cell subsets interact under chronic inflammatory conditions. We studied Th17 and Treg cells isolated from intestinal lamina propria of patients with IBD to investigate their role in pathogenesis.
Methods: FoxP3 expression (a marker of Treg cells) and IL-17 production were assessed in CD4(+) lamina propria lymphocytes isolated from IBD patients and healthy subjects. IL-17(+)FoxP3(+) and IL-17(+) CD4(+) T-cell clones were generated by limiting dilution. An in vitro suppression assay was performed to assess the functional capacity of derived T-cell clones.
Results: IL-17(+)FoxP3(+) T cells were identified in inflamed intestinal mucosa of patients with Crohn disease (CD), but not in patients with ulcerative colitis (UC) or healthy controls. These cells shared phenotypic characteristics of Th17 and Treg cells, and showed potent suppressor activity in vitro. Transforming growth factor-β was necessary and sufficient to induce development of an IL-17(+) FoxP3(+) cell population in CD4(+) lamina propria lymphocytes derived from patients with UC.
Conclusions: The inflammatory environment in the intestinal mucosa of patients with CD contributes to the generation of a distinct population of Treg cells that are FoxP3(+) and produce IL-17. These cells are likely to arise during differentiation of Th17 and Treg cells. Specific microenvironmental cues from tissues are likely to determine their commitment to either lineage and affect the balance between regulation and inflammation in the intestine.
Conflict of interest statement
Disclosures: The authors have no conflict of interests to disclose.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
References
- Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204:1849–1861.
- Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345–350.
- Aujila SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol. 2007;19:377–382.
- Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006;441:235–238.
- Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8:369–377.
- McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-21-IL-17 immune pathway. Trends Immunol. 2006;27:17–23.
- Ouyang W, Kools JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454–467.
- Sakaguchi S, Yamaguchi T, Nomura T, Ono M. FoxP3+ Treg cell functioning in suppression of effector T cells is essential in maintenance of peripheral tolerance. Cell. 2008;133:775–787.
- Zheng Y, Rudensky AY. FoxP3 in control of the regulatory T cell lineage. Nat Immunol. 2007;8:457–462.
- Wan Y, et al. TGF-β and regulatory T cell in immunity and autoimmunity. J Clin Immunol. 2008;28:647–659.
- Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-β induces development of the Th17 lineage. Nature. 2006;441:231–234.
- Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β1 maintains supressor function and FoxP3 expression in CD4+CD25+ regulatory T cells. J Epx Med. 2005;201
- Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcriptional factor FoxP3. J Epx Med. 2003;198:1875–1886.
- Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cells programs. Immunity. 2008;29:44–56.
- Zhou L, Lopes JE, Chong MM, et al. TGF-β-induced FoxP3 inhibits Th17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236–240.
- Koenen HJ, Smeets RL, Vink PM, et al. Human CD25high FoxP3+ regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112:2340–2352.
- Eberl G, Marmon S, Sunshine MJ, et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol. 2004;5:64–73.
- Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor ROR-gammat dirrects the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–1133.
- Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing FoxP3+ regulatory T cells in humans. Proc Natl Acad Sci. 2009;106:4793–4798.
- Fujino S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65–70.
- Nielsen OH, Kirman I, Rüdiger N, et al. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003;38:180–185.
- Seiderer J, Elben I, Diegelmann J, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL-17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis. 2008;14:437–445.
- Duerr RH, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461–1463.
- Dubinsky MC, Wang D, Picornell Y, et al. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis. 2007;13:511–515.
- Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868–1878.
- Saruta M, Yu QT, Fleshner PR, et al. Characterization of FoxP3+ CD4+ regulatory T cells in Crohn's disease. Clinical Immunology. 2007;125:281–290.
- Makita S, Kanai T, Oshima S, et al. CD4+CD25+ bright T cells in human intestinal lamina propria as regulatory cells. J Immunol. 2004;173:3119–3130.
- Liao Fea. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsivenedd to macrophage inflammatory protein 3 a. J Immunol. 1999;162:186–194.
- Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gut-resistant human Th17 cells express CD161 and promote intestinal inflammation. J Epx Med. 2009;206:525–534.
- Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)-17 cells. Nature. 2007;448:484–487.
- Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Epx Med. 2005;201:233–240.
- Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448:480–483.
- Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–189.
- Zhou L, Ivanov II, Spolski R, et al. IL-6 program T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967–974.
- Del Zotto B, Mumolo G, Pronio AM, et al. TGF-β1 production in inflammatory bowel disease:differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol. 2003;134:120–126.
- León AJ, Gómez E, Garrote JA, et al. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm. 2009;2009:580450.
Source: PubMed